Skip to main content
logo
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.61
+0.12 (2.19%)
Mar 17, 2026, 2:05 PM EDT - Market open

Xeris Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
9671,305507325181366
Market Cap Growth
69.42%157.58%56.05%79.10%-50.46%24.75%
Enterprise Value
1,1091,446685.21477.85255.75351.51
Last Close Price
5.617.853.392.351.332.93
PE Ratio
1736.76--9.16-5.22-1.90-1.89
Forward PE
52.7964.50----
PS Ratio
3.304.472.491.981.647.38
PB Ratio
66.6695.32-17.11-47.864.013.84
P/TBV Ratio
70.7999.06-16.80-47.703.992.43
P/FCF Ratio
34.4546.72-13.38-6.59-1.75-3.79
P/OCF Ratio
33.6145.58-13.70-6.90-1.76-3.83
EV/Sales Ratio
3.804.953.372.922.327.09
EV/EBITDA Ratio
29.9439.02-31.76-15.08-3.67-3.10
EV/EBIT Ratio
44.5558.07-20.37-10.86-3.12-3.05
EV/FCF Ratio
39.7151.76-18.10-9.70-2.47-3.64
Debt / Equity Ratio
18.4018.40-8.45-33.284.350.92
Debt / EBITDA Ratio
6.976.97-12.58-7.23-2.84-0.78
Debt / FCF Ratio
9.249.24-7.17-4.65-1.91-0.91
Net Debt / Equity Ratio
10.7410.74-6.75-23.111.68-0.15
Net Debt / EBITDA Ratio
3.973.97-9.26-4.95-1.090.13
Net Debt / FCF Ratio
5.275.27-5.28-3.18-0.740.15
Asset Turnover
0.830.830.630.490.340.21
Inventory Turnover
0.730.730.850.901.061.01
Quick Ratio
1.481.481.121.172.081.52
Current Ratio
2.192.191.671.642.541.80
Return on Equity (ROE)
-6.96%-6.96%301.32%-324.20%-134.83%-190.28%
Return on Assets (ROA)
7.05%7.05%-10.01%-12.93%-24.88%-49.69%
Return on Invested Capital (ROIC)
14.34%14.34%-17.21%-24.28%-58.07%-188.24%
Return on Capital Employed (ROCE)
10.03%10.03%-14.95%-17.66%-33.03%-64.65%
Earnings Yield
0.06%0.00%-10.91%-19.15%-52.63%-52.90%
FCF Yield
2.90%2.14%-7.47%-15.18%-57.06%-26.41%
Buyback Yield / Dilution
-0.87%-0.87%0.40%0.13%-16.76%-7.46%
Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q